Top Markets
Coin of the day
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
Rangering i aksjer #12973
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Aksjekurs
$0.66137861
Markedsverdi
$531.70M
Endring (1 dag)
-2.45%
Endring (1 år)
-42.12%
Land
CN
Handel Ocumension Therapeutics (1477)

Kategori

Aksjeprishistorikk for Ocumension Therapeutics (1477)
Høyeste sluttskurs: $0.68 den 2026-08-01

Laveste sluttskurs: $4.11 den 2020-07-01
Aksjeprishistorikk for Ocumension Therapeutics fra 2020 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -10.84%
2025 66.97%
2024 -28.81%
2023 -25.43%
2022 -45.72%
2021 -33.26%
2020 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$750.94 6.02%
CH